Flower City Capital Kura Oncology, Inc. Call Options Transaction History
Flower City Capital
- $169 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KURA
# of Institutions
192Shares Held
79.4MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$50.3 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$48.1 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$43.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$38.4 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$33.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $415M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...